Ivabradine Versus Beta-blockers in the Treatment of Inappropriate Sinus Tachycardia

NCT01657136 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2016-09-30

No results posted yet for this study

Summary

The aim of this study is to prospectively compare the effectiveness and safety of ivabradine and beta-blockers in the treatment of inappropriate sinus tachycardia.

Conditions

  • Inappropriate Sinus Tachycardia

Interventions

DRUG

Ivabradine

comparison of different drugs

DRUG

Beta blocker

comparison of different drugs

Sponsors & Collaborators

  • Policlinico Casilino ASL RMB

    lead OTHER

Principal Investigators

  • Leonardo Calò, FESC MD · Policlinico Casilino

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-09-30
Primary Completion
2016-09-30
Completion
2016-09-30

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01657136 on ClinicalTrials.gov